The Lancet. Respiratory medicine
The most recent articles from:
Lancet Respir Med
-
Clinical Trial
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
The role of the lung microbiome in the pathogenesis of idiopathic pulmonary fibrosis is unknown. We investigated whether unique microbial signatures were associated with progression of idiopathic pulmonary fibrosis. ⋯ National Institutes of Health.
-
Published data for the epidemiology of idiopathic pulmonary fibrosis in the USA are scarce. We sought to estimate the incidence, prevalence, and mortality risk of idiopathic pulmonary fibrosis among US Medicare beneficiaries. ⋯ Biogen Idec.